Exploring the Potential and Challenges of Neurotechnology and Brain-Computer Interfaces in India
Neurotechnology, particularly Brain-Computer Interfaces (BCIs), uses mechanical tools to interact directly with the human brain. These devices can record or stimulate neural activity, offering hope for treating neurological disorders like Parkinson’s, strokes, and spinal cord injuries. While the U.S. and China lead with initiatives like the BRAIN Initiative and the China Brain Project, India is developing its own capabilities through institutions like IIT Kanpur and IISc. However, the field faces significant ethical hurdles regarding human enhancement and privacy, necessitating a robust regulatory framework to ensure safe and ethical development.
Key Points
- Brain-Computer Interfaces (BCIs) translate neural signals into commands for external devices like prosthetic limbs or computers.
- Neurotechnology has the potential to treat non-communicable diseases and injuries, including paralysis and depression.
- The U.S. BRAIN Initiative and the China Brain Project (2016-2030) are leading global efforts in this field.
- India needs a tailored regulatory pathway to address ethical concerns, data privacy, and user autonomy in neurotechnology.
Exam Facts
- US BRAIN Initiative (launched 2013).
- China Brain Project (2016-2030).
- Neuralink received FDA approval for human trials in May 2024.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.